After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Day One Biopharmaceuticals Inc is $1.25B. A total of 0.9 million shares were traded on the day, compared to an average of 1.01M shares.
In the most recent transaction, Dubow Adam sold 3,202 shares of DAWN for 14.00 per share on Aug 16 ’24. After the transaction, the GENERAL COUNSEL now owns 26,928 company shares. In a previous transaction on Aug 16 ’24, York Charles N II sold 2,633 shares at 14.00 per share. DAWN shares that COO, CFO AND SECRETARY owns now total 232,485.
Among the insiders who sold shares, Blackman Samuel C. disposed of 2,232 shares on Aug 16 ’24 at a per-share price of $14.00. This resulted in the HEAD OF R&D holding 1,127,535 shares of DAWN after the transaction. In another insider transaction, Bender Jeremy sold 10,681 shares at $14.00 per share on Aug 16 ’24. Company shares held by the CHIEF EXECUTIVE OFFICER now total 98,932.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DAWN has a high of $18.07 and a low of $9.67.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DAWN’s latest balance sheet shows that the firm has $284.31M in Cash & Short Term Investments as of fiscal 2021. There were $220.00k in debt and $8.66M in liabilities at the time. Its Book Value Per Share was $3.50, while its Total Shareholder’s Equity was $281.15M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DAWN is Buy with a score of 4.70.
